✦ LIBER ✦

Safety and Immunogenicity of Recombinant Human Thrombin: A Pooled Analysis of Results from 10 Clinical Trials

✍ Scribed by Singla, Neil K.; Foster, Kevin N.; Alexander, W. Allan; Pribble, John P.

Book ID: 118765804
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 62 KB
Volume: 32
Category: Article
ISSN: 0277-0008
DOI: 10.1002/phar.1128

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Immunogenicity Observations P

Safety and Immunogenicity Observations Pooled from Eight Clinical Trials of Recombinant Human Thrombin

✍ Jeffrey L. Ballard; Fred A. Weaver; Neil K. Singla; William C. Chapman; W. Allan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Tolerability of atorvastatin in a popula

Tolerability of atorvastatin in a population aged ≥65 years: A retrospective pooled analysis of results from fifty randomized clinical trials

✍ Judith H. Hey-Hadavi; Erik Kuntze; Don Luo; Paul Silverman; Donald Pittman; Barb 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 916 KB

Safety and tolerability of duloxetine in

Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials

✍ Ernest H. S. Choy; Philip J. Mease; Daniel K. Kajdasz; Madelaine M. Wohlreich; P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 166 KB

TCT-37: Long-Term Safety and Clinical Ef

TCT-37: Long-Term Safety and Clinical Efficacy Outcomes of the Paclitaxel-Eluting Stent from a Patient-Level Pooled Analysis of the TAXUS Clinical Trials

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Safety and immunogenicity of the recombi

Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial

✍ Grode, Leander; Ganoza, Christian A.; Brohm, Christiane; Weiner, January; Eisele 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 730 KB

Safety and tolerability of duloxetine in

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials

✍ James I. Hudson; Madelaine M. Wohlreich; Daniel K. Kajdasz; Craig H. Mallinckrod 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

## Abstract ## Objective To examine the safety and tolerability of the antidepressant duloxetine across multiple studies for major depressive disorder (MDD). ## Method Safety data were integrated from the acute phases of eight double‐blind, placebo‐controlled trials in which patients were random